| Commercialization of nanotechnology. | |
| | |
MedLine Citation:
|
PMID: 20049790 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The emerging and potential commercial applications of nanotechnologies clearly have great potential to significantly advance and even potentially revolutionize various aspects of medical practice and medical product development. Nanotechnology is already touching upon many aspects of medicine, including drug delivery, diagnostic imaging, clinical diagnostics, nanomedicines, and the use of nanomaterials in medical devices. This technology is already having an impact; many products are on the market and a growing number is in the pipeline. Momentum is steadily building for the successful development of additional nanotech products to diagnose and treat disease; the most active areas of product development are drug delivery and in vivo imaging. Nanotechnology is also addressing many unmet needs in the pharmaceutical industry, including the reformulation of drugs to improve their bioavailability or toxicity profiles. The advancement of medical nanotechnology is expected to advance over at least three different generations or phases, beginning with the introduction of simple nanoparticulate and nanostructural improvements to current product and process types, then eventually moving on to nanoproducts and nanodevices that are limited only by the imagination and limits of the technology itself. This review looks at some recent developments in the commercialization of nanotechnology for various medical applications as well as general trends in the industry, and explores the nanotechnology industry that is involved in developing medical products and procedures with a view toward technology commercialization. |
| | |
Authors:
|
David W Hobson |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology Volume: 1 ISSN: 1939-0041 ISO Abbreviation: Wiley Interdiscip Rev Nanomed Nanobiotechnol Publication Date: 2009 Mar-Apr |
Date Detail:
|
Created Date: 2010-01-05 Completed Date: 2010-03-10 Revised Date: 2011-01-14 |
Medline Journal Info:
|
Nlm Unique ID: 101508311 Medline TA: Wiley Interdiscip Rev Nanomed Nanobiotechnol Country: United States |
Other Details:
|
Languages: eng Pagination: 189-202 Citation Subset: IM |
Copyright Information:
|
(c) 2009 John Wiley & Sons, Inc. |
Affiliation:
|
nanoTox Inc., Austin, TX, USA. dhobson@nanotox.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Biotechnology
/
economics*,
trends Industry / economics*, trends Internationality Marketing / economics*, trends Nanotechnology / economics*, trends |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Ferritin nanoparticles as magnetic resonance reporter gene.
Next Document: Occupational exposure to nanomedical applications.